Product Information
POLYTUSSIN DM 7.5-5-12.5 MG/5 ML is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.0623 per ML under NDC 50991013216. Its NADAC has been published 150 times since Nov 22, 2023.
POLYTUSSIN DM 7.5-5-12.5 MG/5 ML
Dextromethorphan HBr, Phenylephrine HCl, Pyrilamine MaleateStrength
7.5; 5; 12.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991013216
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/8/2023
Pharmacological Classes
Price Statistics
The NADAC for POLYTUSSIN DM 7.5-5-12.5 MG/5 ML has been published 150 times since Nov 22, 2023, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0623 per ML |
|---|---|
| All-time high | $0.0697 (Sep 10, 2025) |
| All-time low | $0.0566 (Nov 22, 2023) |
| 52-week high | $0.0696 |
| 52-week low | $0.0623 |
| Median price | $0.0623 |
| Average price | $0.0630 |
| Largest weekly change | +10.9% (Mar 19, 2025) |
| Weeks tracked | 150 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Phenylephrine HCl, Pyrilamine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Phenylephrine HCl, Pyrilamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POLYTUSSIN DM 7.5-5-12.5 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for POLYTUSSIN DM 7.5-5-12.5 MG/5 ML, manufactured by Poly Pharmaceuticals, Inc., is $0.0623 per ML (NDC 50991013216), effective Sep 30, 2026.
How has the price of POLYTUSSIN DM 7.5-5-12.5 MG/5 ML changed over time?
Over the history we have for it, the NADAC for POLYTUSSIN DM 7.5-5-12.5 MG/5 ML has risen 10.1%. It has been tracked across 150 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for POLYTUSSIN DM 7.5-5-12.5 MG/5 ML?
Since Nov 22, 2023, the NADAC for POLYTUSSIN DM 7.5-5-12.5 MG/5 ML has ranged from a low of $0.0566 (Nov 22, 2023) to a high of $0.0697 (Sep 10, 2025), with a median of $0.0623 per ML.
Are there cheaper alternatives to POLYTUSSIN DM 7.5-5-12.5 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of POLYTUSSIN DM 7.5-5-12.5 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POLYTUSSIN DM 7.5-5-12.5 MG/5 ML?
POLYTUSSIN DM 7.5-5-12.5 MG/5 ML (NDC 50991013216) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.